Data, Documentation, and Outcomes Measurement

Teaches accurate study documentation, source-record quality, secure data capture, Good Clinical Practice recordkeeping, IRB and sponsor documentation requirements, monitoring readiness, audit support, accountability, and retention obligations.

8 care stages · 27 guidelines · 0 courses · 0 providers

Teaches how to understand ClinicalTrials.gov records and related study information, including glossary terms, registration fields, protocol descriptors, and results-reporting elements used to interpret clinical research records.

5 care stages · 24 guidelines · 0 courses · 0 providers

Teaches structured monitoring of depressive symptoms, response, and remission across treatment and follow-up. Learners use standardized scales and clinical review to track change and identify deterioration or non-response.

6 care stages · 10 guidelines · 0 courses · 0 providers

Teaches clinicians and research staff to understand the purpose, limits, scoring, interpretation, and clinical meaning of psychological measures and study instruments used to evaluate symptoms, functioning, safety, and treatment outcomes.

7 care stages · 9 guidelines · 0 courses · 0 providers

The study used standardized anxiety measures and followed patients for 2 months and 12 months, implying competence in tracking outcomes over time. Therapists should be able to assess symptom change and sustained benefit using structured follow-up.

5 care stages · 8 guidelines · 0 courses · 0 providers

Therapists/facilitators should be able to judge whether therapeutic change reaches clinically meaningful thresholds, not just whether symptoms improve numerically. This supports informed ongoing care and communication about benefits and limitations.

6 care stages · 5 guidelines · 0 courses · 0 providers

Administer study measures and structured assessments on schedule, including psychological, spiritual, and neurobehavioral instruments. This includes both paper-based and Storyline-based assessments.

5 care stages · 5 guidelines · 0 courses · 0 providers

The facilitator must administer and coordinate patient-rated and clinician-rated measures while minimizing bias. Assessments should be completed independently and in the correct order.

4 care stages · 4 guidelines · 0 courses · 0 providers

Therapists and facilitators should communicate treatment effects responsibly and acknowledge methodological limitations. The paper notes small sample size, lack of long-term control group, and need for further study of mechanisms.

3 care stages · 4 guidelines · 0 courses · 0 providers

The framework implies competence in evaluating both symptom change and subjective outcomes over time. The study used standardized anxiety measures and qualitative interviews to assess sustained effects and patient-reported change.

4 care stages · 3 guidelines · 0 courses · 0 providers

Collect smoking-related behavioral data and participant-reported outcomes repeatedly across the trial. Facilitators must accurately gather self-report, breath CO, urine, and questionnaire data according to protocol.

3 care stages · 3 guidelines · 0 courses · 0 providers

Teaches the use of independent or blinded assessors to reduce expectancy and observer bias, preserve separation between therapeutic and rating roles, manage unblinding risks, and protect outcome validity in open-label or partially blinded designs.

3 care stages · 3 guidelines · 0 courses · 0 providers

Ability to administer standardized clinical ratings consistently and under supervision. Reliable measurement is essential for efficacy and safety endpoints.

4 care stages · 3 guidelines · 0 courses · 0 providers

Although formal measurements may be conducted by another researcher, therapists/facilitators must work within a protocol that includes repeated anxiety assessments and daily diaries of anxiety, pain, and medication use. This implies competence in reinforcing adherence to monitoring procedures and integrating findings into care awareness.

3 care stages · 3 guidelines · 0 courses · 0 providers

Teaches the requirement for site personnel to be trained and certified on protocol-specific assessments, psychiatric instruments, rating scales, and study procedures before performing them in the trial.

4 care stages · 3 guidelines · 0 courses · 0 providers

The facilitator must minimize bias in how assessments are administered and in how participant responses are handled. This is important because the trial is open-label and relies heavily on patient-reported outcomes.

2 care stages · 2 guidelines · 0 courses · 0 providers

Knowledge of the trial’s primary, secondary, and exploratory endpoints and the instruments used to assess them. This enables accurate administration and interpretation of study procedures.

4 care stages · 2 guidelines · 0 courses · 0 providers

Ability to assess whether the target acute psychedelic experience has occurred using the study-defined scale and threshold. This was used to guide individualized dosing.

3 care stages · 2 guidelines · 0 courses · 0 providers

Therapists should accurately represent the current evidence base and avoid overstating efficacy or durability. The article notes significant short-term benefit but also the need for larger multicenter trials and longer follow-up.

2 care stages · 2 guidelines · 0 courses · 0 providers

Ability to manage the study schedule, windows, and follow-up procedures accurately. This supports treatment delivery and valid outcome collection.

4 care stages · 2 guidelines · 0 courses · 0 providers

Maintains accuracy and transparency when using registry sources for competency extraction. The facilitator should avoid overclaiming details that are not present in the available record text.

1 care stage · 2 guidelines · 0 courses · 0 providers

Because cognitive performance during treatment is a named secondary outcome, clinicians involved in care should be able to monitor and document cognitive functioning relevant to treatment participation. This supports safety oversight and interpretation of treatment effects.

3 care stages · 2 guidelines · 0 courses · 0 providers

The therapist/facilitator or designated rater must administer and interpret multiple structured clinical scales reliably. Training and separation of roles are required to preserve rating quality and blinding.

3 care stages · 2 guidelines · 0 courses · 0 providers

Teaches how to interpret the psychedelic clinical evidence base, compare strength of evidence across indications, understand mechanism theories, and critically appraise research claims. The competency supports evidence-informed practice rather than relying on general field narratives.

7 care stages · 1 guidelines · 11 courses · 8 providers

Competent delivery includes monitoring psychosocial functioning in addition to depressive symptoms. The source reports psychosocial functioning as a treatment outcome sustained through follow-up.

3 care stages · 1 guidelines · 0 courses · 0 providers

Administer study assessments in the correct order and in the correct format. The protocol depends on reliable, standardized administration by trained site personnel and central raters.

3 care stages · 1 guidelines · 0 courses · 0 providers

Demonstrate standardized rating competence and maintain reliable measurement over time. The protocol emphasizes training, calibration, and ongoing checks to prevent drift.

1 care stage · 1 guidelines · 0 courses · 0 providers

Ability to contribute to evaluation of the effectiveness of LSD-assisted psychotherapy. The study is explicitly described as investigating safety and effectiveness.

2 care stages · 1 guidelines · 0 courses · 0 providers

Recognize that strong psychoactive effects can reveal treatment allocation and influence ratings. This awareness is important for interpreting subjective reports and maintaining methodological rigor.

1 care stage · 1 guidelines · 0 courses · 0 providers

Trained staff must administer and/or supervise a battery of behavioral tasks and self-report instruments consistently across baseline and drug sessions. Some measures are verbally administered by clinicians or coordinators and require standardized delivery.

3 care stages · 1 guidelines · 0 courses · 0 providers

Uses observed patient response to help optimize how ketamine-assisted psychotherapy is administered. Informs future clinical decisions about approach and dosing strategy.

1 care stage · 1 guidelines · 0 courses · 0 providers

After completion of PE, patients are assessed over a 3-month follow-up period at multiple time points, requiring clinician or facilitator competence in longitudinal follow-up procedures. This includes maintaining contact and collecting outcome information consistently.

2 care stages · 1 guidelines · 0 courses · 0 providers

Collects and records substance use, withdrawal, and follow-up data accurately and responsibly in clinical or research settings.

2 care stages · 1 guidelines · 0 courses · 0 providers

Clinicians should be able to evaluate and support treatment acceptability from both participant and clinician perspectives. The pilot reported high acceptability ratings by participants and study clinicians.

1 care stage · 1 guidelines · 0 courses · 0 providers

Understands the obligation to follow defined data element standards when submitting or interpreting study information. This is relevant to accurate, non-misleading representation of therapist/facilitator qualifications.

1 care stage · 1 guidelines · 0 courses · 0 providers

Responsibility to use study information appropriately and in accordance with registry expectations. This includes respecting the limits of what can be inferred from the record text alone.

1 care stage · 1 guidelines · 0 courses · 0 providers

Uses publicly available trial information responsibly and within its intended scope. Respects that registry content is not a substitute for clinical judgment, consent procedures, or study-specific training.

1 care stage · 1 guidelines · 0 courses · 0 providers

Understand that changes in cerebral blood flow were observed after ayahuasca intake in regions implicated in mood and emotion regulation. Facilitators should be able to contextualize these findings without overinterpreting them clinically.

2 care stages · 1 guidelines · 0 courses · 0 providers

The protocol includes secondary outcomes for depression and anxiety severity, so clinicians should be able to assess and track these domains alongside PTSD symptoms. This broadens case monitoring and supports comprehensive clinical oversight.

2 care stages · 1 guidelines · 0 courses · 0 providers

Because study drug delivery uses a vaporization device, staff must be able to recognize, document, and escalate device deficiencies. Device issues may have safety implications even when no patient harm occurs.

2 care stages · 1 guidelines · 0 courses · 0 providers

Sequences study procedures correctly to reduce bias and protect participant safety. Particularly prioritizes PROs, clinician ratings, and dosing-day procedures in the required order.

3 care stages · 1 guidelines · 0 courses · 0 providers

Understands that findings from a pilot evaluation support feasibility and preliminary effectiveness rather than definitive efficacy. The facilitator should interpret outcomes cautiously and support structured data collection.

1 care stage · 1 guidelines · 0 courses · 0 providers

Prepare participants for the dosing session and guide them through standardized procedures. The facilitator should ensure readiness, adherence to study rules, and smooth progression through the session schedule.

3 care stages · 1 guidelines · 0 courses · 0 providers

Knowledge of placebo-controlled treatment design and the interpretive issues it raises in psychotherapy research. This supports appropriate understanding of efficacy findings.

1 care stage · 1 guidelines · 0 courses · 0 providers

Awareness of the need to use official data element definitions when submitting registration or results information. This reflects adherence to accurate and compliant trial reporting practices.

1 care stage · 1 guidelines · 0 courses · 0 providers

Responsibility to treat study information in a manner consistent with registration and results-reporting requirements. This includes using official definitions rather than improvising field content.

1 care stage · 1 guidelines · 0 courses · 0 providers

Knowledge of clinical trial methods and evaluation approaches relevant to psychotherapy research. The source indicates controlled clinical trial and analysis of variance contexts.

1 care stage · 1 guidelines · 0 courses · 0 providers

The therapist should assess both the immediate experience and longer-term change, using structured observation, self-report, and reports from others where possible. The handbook treats evaluation as difficult but necessary for understanding therapeutic effects.

3 care stages · 1 guidelines · 0 courses · 0 providers

The protocol depends on video/audio recordings for later transcription, qualitative coding, and adherence review. Staff must understand how these recordings support both science and supervision.

1 care stage · 1 guidelines · 0 courses · 0 providers

Some listed programs explicitly teach clinical documentation and related practice management skills. This suggests learners may be expected to document care, coordinate treatment processes, and work within structured clinical workflows.

6 care stages · 0 guidelines · 1 courses · 1 providers

The page highlights best-in-class clinical training for drug trials and AI-supported evaluation. Learners are expected to refine skills quickly and receive targeted feedback in training or evaluation contexts.

8 care stages · 0 guidelines · 1 courses · 1 providers

The practicum includes retreat team debriefs, supervisor meetings, and assessment presentations. This signals an expectation that learners can reflect on practice, receive feedback, and integrate learning.

6 care stages · 0 guidelines · 1 courses · 1 providers

Trainees receive templates such as consent and intake forms, informational documents, and guidelines, which implies competence in using standardized practice materials. The page also signals procedural support for safe and organized care delivery.

5 care stages · 0 guidelines · 1 courses · 1 providers

Teaches protection of participant identity, sensitive clinical or occupational information, recordings, and research data. The competency covers coded identifiers, restricted access, secure handling, confidentiality safeguards, and privacy-preserving documentation.

6 care stages · 53 guidelines · 0 courses · 0 providers

Teaches how to detect, elicit, document, and report adverse events and serious adverse events across the participant journey. The focus is accurate source documentation, regulatory reporting discipline, follow-up, and preservation of participant safety and trial integrity.

7 care stages · 46 guidelines · 0 courses · 0 providers

Teaches faithful delivery of manualized treatment and protocol-defined procedures while documenting and managing unavoidable deviations. The competency protects participant welfare, treatment consistency, data integrity, and sponsor oversight.

7 care stages · 39 guidelines · 0 courses · 0 providers

Teaches ongoing participant contact after dosing to support stability, detect delayed adverse effects, maintain therapeutic containment, and sustain adherence to follow-up visits and outcome assessments.

7 care stages · 37 guidelines · 0 courses · 0 providers

Teaches how to preserve blinded trial conduct across participant interactions, outcome collection, staff roles, and session procedures. The competency includes preventing accidental unblinding, minimizing bias, and using emergency unblinding only when clinically necessary.

8 care stages · 29 guidelines · 0 courses · 0 providers

Teaches adherence to Good Clinical Practice, assigned study roles, protocol procedures, delegation boundaries, and applicable research regulations. The competency supports consistent execution of approved procedures across sites and participants.

5 care stages · 15 guidelines · 0 courses · 0 providers

Teaches recognition and documentation of dissociation, psychosis-like symptoms, mania, and other acute neuropsychiatric effects that can occur after ketamine, psychedelic dosing, or related interventions. The focus is monitoring, reporting, and escalation when symptoms become clinically significant.

7 care stages · 12 guidelines · 0 courses · 0 providers

Teaches structured clinical interviewing and assessment administration for PTSD and related symptom domains, including symptom severity, functional impairment, risk factors, and appropriate use of standardized assessment tools.

7 care stages · 7 guidelines · 0 courses · 0 providers

Cluster covering 4 related competencies including: Integration and debriefing, Integration and debriefing facilitation, Integration and post-session debriefing.

6 care stages · 6 guidelines · 0 courses · 0 providers

Ability to administer and interpret structured interviews, clinician ratings, and self-report measures used in the study. Therapists contribute to eligibility, safety, and outcome assessment.

7 care stages · 5 guidelines · 0 courses · 0 providers

Facilitators must competently administer and interpret clinician-rated ADHD and global severity measures. Accurate scoring is essential because these scales determine eligibility and outcomes.

4 care stages · 4 guidelines · 0 courses · 0 providers

Ability to evaluate alcohol and other substance use patterns using standardized tools and clinical interview. This is essential for eligibility, safety, and outcome monitoring.

4 care stages · 4 guidelines · 0 courses · 0 providers

Because the paper notes limited conclusions about efficacy due to the crossover design, clinicians have an ethical responsibility to avoid overstating treatment effects. Competence includes accurately presenting the evidence base, uncertainty, and limits of inference to patients and colleagues.

2 care stages · 3 guidelines · 0 courses · 0 providers

Administer and interpret psychological and psychometric measures relevant to mood, cravings, expectations, mystical experience, ego dissolution, and functioning. Facilitators must accurately support questionnaire-based assessment across time points.

5 care stages · 3 guidelines · 0 courses · 0 providers

Ability to monitor for opioid use recurrence, other substance use, and ketamine misuse during the trial. The clinician must recognize relapse risk and take action when substance use worsens.

3 care stages · 3 guidelines · 0 courses · 0 providers

Ability to monitor for short-term cognitive impairment following psychedelic administration. The study included tests designed to detect decrements in attention and processing speed.

3 care stages · 2 guidelines · 0 courses · 0 providers

Safety monitoring in this context includes tracking not only adverse psychiatric states but also broader psychological, emotional, existential, and spiritual outcomes. Clinicians should watch for changes across multiple domains that may affect patient functioning and care needs.

3 care stages · 2 guidelines · 0 courses · 0 providers

Understands the optional nature and operational limits of biomarker and pharmacogenomic collection. Ensures consent, timing, fasting guidance, and sample handling requirements are respected.

3 care stages · 2 guidelines · 0 courses · 0 providers

Therapists/facilitators should know the main assessment domains used in KPT research and clinical monitoring, including craving, depression, anxiety, anhedonia, addiction severity, and purpose in life. This knowledge supports case formulation and tracking change.

2 care stages · 2 guidelines · 0 courses · 0 providers

Work within a supervised treatment model that includes review of recorded sessions and feedback. The facilitator must accept supervision, use feedback constructively, and support fidelity reviews.

2 care stages · 2 guidelines · 0 courses · 0 providers

Administer and interpret the study's psychosocial measures relevant to existential distress, depression, spiritual well-being, and death-related distress. These assessments are used for screening and outcome monitoring.

2 care stages · 1 guidelines · 0 courses · 0 providers

Treat participant disclosures during interviews and integration as sensitive clinical information. The facilitator should elicit and document experiences respectfully and without judgment.

1 care stage · 1 guidelines · 0 courses · 0 providers

Document eligibility decisions, registrations, and protocol compliance accurately and completely. This includes signed checklists, source documentation, and investigator attestation.

1 care stage · 1 guidelines · 0 courses · 0 providers

Facilitator supports between-session practice and adherence to study procedures. Participants are expected to practice skills daily and complete smartphone-based EMA.

1 care stage · 1 guidelines · 0 courses · 0 providers

The study examines whether early improvement during PE relates to dropout rates, implying a competency in recognizing early response patterns and engagement risk. Therapists should monitor participation closely and intervene to support retention when possible.

2 care stages · 1 guidelines · 0 courses · 0 providers

Ask about symptoms and adverse effects in a neutral, non-suggestive manner. This reduces bias and improves safety detection in a vulnerable oncology population.

2 care stages · 1 guidelines · 0 courses · 0 providers

Understands core pharmacokinetic concepts needed to interpret study findings and guide safety observation. Recognizes dose-linear exposure changes and elimination characteristics relevant to monitoring windows.

2 care stages · 1 guidelines · 0 courses · 0 providers

Coordinate multi-visit assessment timelines around the psilocybin session. Follow-up data collection is essential for longitudinal outcomes and requires careful scheduling.

3 care stages · 1 guidelines · 0 courses · 0 providers

Supports rigorous conduct of randomized controlled safety studies by maintaining protocol adherence and minimizing bias. Protects the validity of safety, tolerability, and exploratory efficacy assessments.

3 care stages · 1 guidelines · 0 courses · 0 providers

Prepare participants to complete emotional processing tasks and questionnaires accurately. Staff must teach task procedures and ensure participants understand expectations before scanning and follow-up assessments.

3 care stages · 1 guidelines · 0 courses · 0 providers

Facilitators must know the study timeline to conduct therapy and safety checks at the correct times. They should understand which visits are in person, virtual, or questionnaire-only and what assessments occur at each stage.

5 care stages · 1 guidelines · 0 courses · 0 providers

The study relied on self-reported symptomatology, so clinicians should understand how to gather and interpret patient-reported outcomes relevant to psychiatric and existential distress. This includes using subjective reports as meaningful indicators while recognizing their limits.

2 care stages · 1 guidelines · 0 courses · 0 providers

Because this is a randomized controlled trial comparing ketamine with active placebo, clinicians must respect trial procedures that protect scientific integrity and participant welfare. This includes adherence to allocation procedures and avoiding actions that could compromise blinding.

1 care stage · 1 guidelines · 0 courses · 0 providers

The page repeatedly points learners to manuals, checklists, PDFs, and reference materials, indicating a practical emphasis on coordination and structured preparation. This suggests learners should be able to organize session materials and support process consistency.

4 care stages · 0 guidelines · 1 courses · 1 providers

Students complete 50 supervised practicum hours and receive expert feedback while working with real clients. This is intended to translate theory into competent applied practice.

7 care stages · 0 guidelines · 1 courses · 1 providers